![](/img/cover-not-exists.png)
Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis Of The Aurelia Trial
Schaffer, EM, Coles, TM, Wysham, WZ, Roque, DR, Kim, KH, Wheeler, SBVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.1193
Date:
November, 2015
File:
PDF, 51 KB
english, 2015